Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 1:11 AM
NCT ID:
NCT03584893
Eligibility Criteria:
Inclusion Criteria:
* Providing the written informed consent form
* The patient should be diagnosed with idiopathic bilateral juvenile cataract
* Idiopathic bilateral juvenile cataract should be diagnosed while the patient must be take a day from one year (age)
* Syria ciziten who take their citizenship of Turkey could be enrolled to the study after signing of Informed Consent Form that translated to mother tongue by sworn translation office approved by ethic committee.
Exclusion Criteria:
* If the patient has been diagnosed with CTX before his/her enrollment in the study,
* If the patient has been diagnosed with cataract due to any known reasons other than CTX including cataracts related to trauma,
* If the patient has been diagnosed with cataract due to cataractogenic treatments,
* If the patient has participated in an interventional clinical study within the last 30 days,
* If the patient and/or his/her legal representative does not provide consent to participate in the study,
* If the patient will not be able to fulfill study requirements according to the investigator's opinion,
* If the patient had used cholic acid or chenodeoxycholic acid on or before the date of participation in the study
* Pregnancy and/or lactation
* Syria citizen that have not Turkey citizenship will not enroll to the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Study:
NCT03584893
Study Brief:
Protocol Section:
NCT03584893